Research Purposes Only. NOT FOR HUMAN CONSUMPTION
$80.00 – $150.00
Cagrilintide is a synthetic, long-acting analog of amylin, a pancreatic hormone that regulates satiety and blood sugar. As a dual amylin and calcitonin receptor agonist, it promotes weight loss by reducing appetite, slowing gastric emptying, and decreasing food intake. It’s under investigation for obesity and type 2 diabetes, often in combination with semaglutide (CagriSema), showing significant weight loss (up to 20.4% over 68 weeks) and improved glycemic control in clinical trials.
THIS IS NOT FOR HUMAN CONSUMPTION. SOLD FOR RESEARCH ONLY!
By pressing the button “Subscribe”, you confirm that you have read
and are agreeing to our Terms of Service regarding the storage of the
data submitted through this form.
Please note that all products featured on this website are intended exclusively for research and development purposes. They are not designed for any form of human consumption. The claims made on this website have not undergone evaluation by the U.S. Food and Drug Administration.
Neither the statements nor the products of this company aim to diagnose, treat, cure, or ward off any disease.
Penguin Peptides is a chemical supplier. Penguin Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Penguin Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.